Boyds agrees deal for Blue Duck Consulting

Pharmaceutical and biotech product development consultancy Boyds has enhanced its clinical and medical affairs services offering with the acquisition of Blue Duck Consulting. Since 2013, Blue Duck provides expert preclinical and clinical drug development strategies and specialist monitoring and project management of clinical operations services in a range of therapeutic areas. Blue Duck was founded by Dr Karen O’Hanlon, a programme manager with 17 years’ experience at firms including hVIVO and SRA Global Clinical Developments, and will join Boyds as director of clinical operations.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.